We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TPST market cap is 41.9M. The company's latest EPS is USD -0.6757 and P/E is -1.41.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.59M | -7.51M | -7.97M | -9.58M | -10.55M |
| Net Income | -6.79M | -7.49M | -7.9M | -9.57M | -10.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -45.4M | -35.97M | -26.99M | -34.64M | -29.16M |
| Net Income | -44.57M | -36.41M | -28.3M | -35.71M | -29.49M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.99M | 51.6M | 44.38M | 42.17M | 33.84M |
| Total Liabilities | 25.18M | 24.84M | 23.75M | 25.23M | 22.38M |
| Total Equity | -1.19M | 26.77M | 20.63M | 16.94M | 11.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 74.97M | 43.41M | 73.24M | 46.09M | 51.6M |
| Total Liabilities | 15.1M | 9.68M | 37.12M | 27.98M | 24.84M |
| Total Equity | 59.87M | 33.73M | 36.12M | 18.11M | 26.77M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.18M | -27.36M | -7.19M | -12.7M | -22.88M |
| Investing | -163k | -170k | -168k | -417k | -432k |
| Financing | 1.25M | 35.6M | 450k | 5.01M | 6.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -41.22M | -30.44M | -25.96M | -31.07M | -27.36M |
| Investing | 3.99M | -26k | -97k | -562k | -170k |
| Financing | 26.94M | 5.39M | 59.06M | 11.4M | 35.6M |
| Market Cap | 41.9M |
| Price to Earnings Ratio | -1.41 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.06 |
| Price to Book Ratio | 1.55 |
| Dividend Yield | - |
| Shares Outstanding | 43.64M |
| Average Volume (1 week) | 608.44k |
| Average Volume (1 Month) | 1.47M |
| 52 Week Change | -76.00% |
| 52 Week High | 6.00 |
| 52 Week Low | 0.6986 |
| Spread (Intraday) | 0.01 (1.02%) |
| Company Name | Tempest Therpeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.tempesttx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
